Selegiline hydrochloride

Selegiline A selective, irreversible inhibitor of Type B monoamine oxidase. It is used in newly diagnosed patients with Parkinson's disease. It may slow progression of the clinical disease and delay the requirement for levodopa therapy. It also may be given with levodopa upon onset of disability. (From AMA Drug Evaluations Annual, 1994, p385) The compound without isomeric designation is Deprenyl.

Molecular Formula: C₁₃H₁₈ClN

InChI: InChI=1/C13H17N.ClH/c1-4-10-14(3)12(2)11-13-8-6-5-7-9-13;/h1,5-9,12H,10-11H2,2-3H3;1H/t12-;/m1./s1

InChIKey: InChIKey=IYETZZCWLLUHIJ-UTONKHPSBZ
SMILES: CC(CC1=CC=CC=C1)N(C)CC#C.Cl

Names:
    Eldepryl hydrochloride
    FPF1100
    HSDB 7183
    Jumex hydrochloride
    l-Deprenyl hydrochloride
    N-methyl-N-[(2R)-1-phenylpropan-2-yl]prop-2-yn-1-amine hydrochloride
    Selegiline hydrochloride [USAN]
    Selegiline hydrochloride
    (-)-Deprenil hydrochloride
    (-)-Deprenyl hydrochloride
    (-)-E-250 hydrochloride

Registries:
    PubChem CID 26758
    PubChem ID 169454